56
Participants
Start Date
April 10, 2019
Primary Completion Date
November 30, 2022
Study Completion Date
September 29, 2023
TTX-030
Variable dose and schedule
Pembrolizumab
Dose and schedule per standard of care
Gemcitabine
Dose and schedule per standard of care
nab paclitaxel
Dose and schedule per standard of care
Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx
UPMC Hillman Cancer Center, Pittsburgh
Sylvester Comprehensive Cancer Center, Miami
Sarah Cannon Research Institute, Nashville
West Cancer Center and Research Institute, Germantown
Norton Cancer Institute, Louisville
University Hospitals Cleveland Medical Center, Cleveland
Nebraska Cancer Center Oncology Hematology West P.C., Omaha
NEXT Oncology, San Antonio
Huntsman Cancer Intitute, Salt Lake City
UC Irvine Cancer Center, Orange
University of California, San Francisco, San Francisco
UC Davis Comprehensive Cancer Center, Sacramento
Rutgers Cancer Institute of New Jersey, New Brunswick
Trishula Therapeutics, Inc.
INDUSTRY